Immunohistochemical expression of carbonic anhydrase IX assessed over time and during treatment in renal cell carcinoma

BJU Int. 2008 Jun:101 Suppl 4:41-4. doi: 10.1111/j.1464-410X.2008.07649.x.

Authors

Hanne Krogh Jensen¹, Marianne Nordsmark, Frede Donskov, Niels Marcussen, Hans von der Maase

Affiliation

¹ Department of Oncology, Aarhus University Hospital, Aarhus C, Denmark. [email protected]

PMID: 18430123
DOI: 10.1111/j.1464-410X.2008.07649.x

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antigens, Neoplasm / metabolism*
Antineoplastic Agents / therapeutic use*
Carbonic Anhydrase IX
Carbonic Anhydrases / metabolism*
Carcinoma, Renal Cell / enzymology*
Carcinoma, Renal Cell / pathology
Carcinoma, Renal Cell / therapy
Clinical Trials, Phase II as Topic
Cohort Studies
Humans
Immunohistochemistry
Interleukin-2 / therapeutic use*
Kidney Neoplasms / enzymology*
Kidney Neoplasms / pathology
Kidney Neoplasms / therapy
Nephrectomy*
Prospective Studies
Retrospective Studies
Treatment Outcome

Substances

Antigens, Neoplasm
Antineoplastic Agents
Interleukin-2
CA9 protein, human
Carbonic Anhydrase IX
Carbonic Anhydrases